ArticleMikrochimica acta2026
Biocompatible molecularly imprinted polynorepinephrine nanoparticles: rational design and one-step reversible immobilization for enhanced protein recognition by surface plasmon resonance.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polynorepinephrine nanoparticles (PNE-NPs) are emerging bioinspired nanomaterials with significant potential in diagnostics and therapy, yet their systematic synthesis and functional assessment remain limited. In this work, a Design of Experiments approach was applied to optimize the synthesis of non-imprinted and imprinted PNE-NPs. A green, pH-triggered precipitation/redispersion protocol was introduced for nanoparticle purification, providing fast and reproducible recovery without organic solvents, and surpassing conventional membrane dialysis methods, which are typically long and labor-intensive. Key parameters (pH, temperature, reaction time, stirring, and monomer concentration) were screened in H2O/NaOH and TRIS buffer media. Optimized PNE-NPs displayed hydrodynamic diameters below 200 nm, spherical morphology, and negligible cytotoxicity in HaCaT keratinocytes across a broad concentration range. As a model study, PNE-NPs were imprinted against the Fc portion of human IgG1 and tested as synthetic receptors by surface plasmon resonance (SPR). Two flow-mode immobilization strategies were compared on bare gold chips: covalent grafting on thiol-modified gold and direct adsorption. Both allowed real-time, in-flow monitoring and markedly improved affinity (KD < 10−8 mol L−1) compared to previous imprinted PNE nanofilms. The adsorption protocol stood out for its simplicity, high affinity and selectivity (α > 27.4), and full in situ reconditioning of the SPR gold transducer with NaClO washes, enabling multiple reuse cycles. These results establish PNE-NPs as versatile synthetic receptors, highlighting their promise as next-generation platforms for diagnostics and therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.